Galderma introduces Alastin in China, supporting the skin’s natural regenerative abilities in a rapidly expanding market: Zug, Switzerland Thursday, September 11, 2025, 14:00 Hr ...

US FDA grants fast track designation to Greenwich LifeSciences’ GLSI-100 in the HLA-A*02 patient population: Stafford, Texas Thursday, September 11, 2025, 16:00 Hrs [IST] Greenw ...

Akeso presents positive data from phase Ib/II study of cadonilimab & pulocimab combination in patients with IO-resistant NSCLC at 2025 WCLC: Hong Kong Thursday, September 11, 2025 ...

Our Bureau, Mumbai Thursday, September 11, 2025, 16:30 Hrs [IST] ...

Stockholm, Sweden Thursday, September 11, 2025, 11:00 Hrs [IST] ...

Apollo MD calls healthcare and medical tourism India’s next engines of services-led growth: Our Bureau, Bengaluru Thursday, September 11, 2025, 14:30 Hrs [IST] Suneeta Reddy, pr ...

There is pressing need for third-party, tech-enabled training to enforcement agencies: BDCDA: Nandita Vijayasimha, Bengaluru ...

Biocon, an innovation-led global biopharmaceutical company, announced the inauguration of its first US manufacturing facility in Cranbury, New Jersey, by its wholly owned subsidiary, Biocon Generics ...

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that it has completed enrollment in the phase 3 SENTRY trial, which is evaluating ...

WHO announces the development of guidelines on multiplex testing: Geneva Thursday, September 11, 2025, 15:00 Hrs [IST] The World Health Organization (WHO) is convening a Guideline ...

PCI once again opens portal for institutes to submit additional information for approval: Gireesh Babu, New Delhi Thursday, ...

Sanofi to present new data from 14 abstracts across multiple sclerosis at ECTRIMS 2025 congress in Barcelona, Spain: Paris Thursday, September 11, 2025, 13:00 Hrs [IST] New data f ...